Role of resistin as a marker of inflammation in systemic lupus erythematosus

Arthritis Research and Therapy

Volumn 10, Issue 1, 2008, Pages

  Almehed, Katarina ^a   d'Elia, Helena Forsblad ^a   Bokarewa, Maria ^a   Carlsten, Hans ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; COMPLEMENT COMPONENT C3; CREATININE; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LIPID; PROCOLLAGEN; PROCOLLAGEN TYPE 1; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; KIDNEY DISEASE; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VERTEBRA FRACTURE; BLOOD; GLOMERULUS FILTRATION RATE; KIDNEY; METABOLISM; MIDDLE AGED; PREVALENCE; SPINE FRACTURE; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; BONE DENSITY; FEMALE; GLOMERULAR FILTRATION RATE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; KIDNEY; KIDNEY DISEASES; LIPOPROTEINS, HDL; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PREVALENCE; RESISTIN; SPINAL FRACTURES;

EID: 39549104687     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2366     Document Type: Article

References (35)

1. Steppan CM Bailey ST Bhat S Brown EJ Banerjee RR Wright CM Patel HR Ahima RS Lazar MA The hormone resistin links obesity to diabetes Nature 2001, 409:307-312. 10.1038/35053000 11201732
2. Kim KH Lee K Moon YS Sul HS A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation J Biol Chem 2001, 276:11252-11256. 10.1074/jbc.C100028200 11278254
3. Holcomb IN Kabakoff RC Chan B Baker TW Gurney A Henzel W Nelson C Lowman HB Wright BD Skelton NJ Frantz GD Tumas DB Peale FV Jr Shelton DL Hébert CC FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family EMBO J 2000, 19:4046-4055. 306596 10921885 10.1093/emboj/19.15.4046
4. Migita K Maeda Y Miyashita T Kimura H Nakamura M Ishibashi H Eguchi K The serum levels ofresistin in rheumatoid arthritis patients Clin Exp Rheumatol 2006, 24:698-701. 17207388
5. Karmiris K Koutroubakis IE Xidakis C Polychronaki M Voudouri T Kouroumalis EA Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease Inflamm Bowel Dis 2006, 12:100-105. 10.1097/01.MIB.0000200345.38837.46 16432373
6. McTernan PG Kusminski CM Kumar S Resistin Curr Opin Lipidol 2006, 17:170-175. 10.1097/01.mol.0000217899.59820.9a 16531754
7. Malyszko J Malyszko JS Pawlak K Mysliwiec M Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients Transplant Proc 2006, 38:3434-3436. 10.1016/ j.transproceed.2006.10.140 17175295
8. Hui-Bing H Migita K Miyashita T Maeda Y Nakamura M Yatsuhashi H Ishibashi H Eguchi K Kimura H Relationship between serum resistin concentrations and inflammatory markers in patients with type 2 diabetes mellitus Metabolism 2006, 55:1670-1673. 10.1016/j.metabol.2006.08.008 17142142
9. Patel L Buckels AC Kinghorn IJ Murdock PR Holbrook JD Plumpton C Macphee CH Smith SA Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators Biochem Biophys Res Commun 2003, 300:472-476. 10.1016/S0006-291X(02)02841-3 12504108
10. Nagaev I Bokarewa M Tarkowski A Smith U Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes PLoS ONE 2006, 1:e31. 1762367 17183659 10.1371/ journal.pone.0000031
11. Bokarewa M Nagaev I Dahlberg L Smith U Tarkowski A Resistin, an adipokine with potent proinflammatory properties J Immunol 2005, 174:5789-5795. 15843582
12. Yaturu S Reddy RD Rains J Jain SK Plasma and urine levels of resistin and adiponectin in chronic kidney disease Cytokine 2007, 37:1-5. 10.1016/ j.cyto.2007.02.003 17383891
13. Thommesen L Stunes AK Monjo M Grøsvik K Tamburstuen MV Kjøbli E Lyngstadaas SP Reseland JE Syversen U Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism J Cell Biochem 2006, 99:824-834. 10.1002/jcb.20915 16721825
14. Almehed K Forsblad d'Elia H Kvist G Ohlsson C Carlsten H Prevalence and risk factors of osteoporosis in female SLE patients-extended report Rheumatology (Oxford) 2007, 46:1185-1190. 10.1093/rheumatology/kem105 17500075
15. Tan EM Cohen AS Fries JF Masi AT McShane DJ Rothfield NF Schaller JG Talal N Winchester RJ The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101 7138600
16. Bombardier C Gladman DD Urowitz MB Caron D Chang CH Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE Arthritis Rheum 1992, 35:630-640. 10.1002/ art.1780350606 1599520
17. Gladman DD Urowitz MB Goldsmith CH Fortin P Ginzler E Gordon C Hanly JG Isenberg DA Kalunian K Nived O Petri M Sanchez-Guerrero J Snaith M Sturfelt G The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus Arthritis Rheum 1997, 40:809-813. 10.1002/art.1780400506 9153540
18. Cockcroft DW Gault MH Prediction of creatinine clearance from serum creatinine Nephron 1976, 16:31-41. 1244564
19. Genant HK Wu CY van Kuijk C Nevitt MC Vertebral fracture assessment using a semiquantitative technique J Bone Miner Res 1993, 8:1137-1148. 8237484
20. Adler AI Stevens RJ Neil A Stratton IM Boulton AJ Holman RR UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes Diabetes Care 2002, 25:894-899. 10.2337/diacare.25.5.894 11978687
21. Senolt L Housa D Vernerová Z Jirásek T Svobodová R Veigl D Anderlová K Müller-Ladner U Pavelka K Haluzík M Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum Ann Rheum Dis 2007, 66:458-463. 10.1136/ard.2006.054734 17040961
22. Pantsulaia I Livshits G Trofimov S Kobyliansky E Genetic and environmental determinants of circulating resistin level in a community-based sample Eur J Endocrinol 2007, 156:129-135. 10.1530/ eje.1.02311 17218736
23. Haugen F Jorgensen A Drevon CA Trayhurn P Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes FEBS Lett 2001, 507:105-108. 10.1016/S0014-5793(01)02968-4 11682067
24. Osawa H Tabara Y Kawamoto R Ohashi J Ochi M Onuma H Nishida W Yamada K Nakura J Kohara K Miki T Makino H Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population Diabetes Care 2007, 30:1501-1506. 10.2337/dc06-1936 17384338
25. Norata GD Ongari M Garlaschelli K Raselli S Grigore L Catapano AL Plasma resistin levels correlate with determinants of the metabolic syndrome Eur J Endocrinol 2007, 156:279-284. 10.1530/eje.1.02338 17287419
26. Svenungsson E Gunnarsson I Fei GZ Lundberg IE Klareskog L Frostegard J Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus Arthritis Rheum 2003, 48:2533-2540. 10.1002/ art.11264 13130473
27. Borba EF Bonfa E Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies Lupus 1997, 6:533-539. 10.1177/096120339700600610 9256312
28. Kashef S Ghaedian MM Rajaee A Ghaderi A Dyslipoproteinemia during the active course of systemic lupus erythematosus in association with anti-double-stranded DNA (anti-dsDNA) antibodies Rheumatol Int 2007, 27:235-241. 10.1007/s00296-006-0195-3 16944155
29. Ettinger WH Goldberg AP Applebaum-Bowden D Hazzard WR Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids Am J Med 1987, 83:503-508. 10.1016/0002-9343(87)90762-5 3661587
30. Khovidhunkit W Kim MS Memon RA Shigenaga JK Moser AH Feingold KR Grunfeld C Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host J Lipid Res 2004, 45:1169-1196. 10.1194/jlr.R300019-JLR200 15102878
31. Hahn BH Grossman J Chen W McMahon M The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: Roles of inflammation and dyslipidemia J Autoimmun 2007, 28:69-75. 10.1016/j.jaut.2007.02.004 17433865
32. Risch L Saely C Hoefle G Rein P Langer P Gouya G Marte T Aczel S Drexel H Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function Clin Chim Acta 2007, 376:108-113. 10.1016/j.cca.2006.07.026 16956602
33. Nusken KD Kratzsch J Wienholz V Stohr W Rascher W Dotsch J Circulating resistin concentrations in children depend on renal function Nephrol Dial Transplant 2006, 21:107-112. 10.1093/ndt/gfi084 16144855
34. Kaser S Kaser A Sandhofer A Ebenbichler CF Tilg H Patsch JR Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro Biochem Biophys Res Commun 2003, 309:286-290. 10.1016/ j.bbrc.2003.07.003 12951047
35. Oh KW Lee WY Rhee EJ Baek KH Yoon KH Kang MI Yun EJ Park CY Ihm SH Choi MG Yoo HJ Park SW The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men Clin Endocrinol (Oxf) 2005, 63:131-138. 10.1111/j.1365-2265.2005.02312.x 16060905